Canopy Growth Corp (TSE:WEED – Get Free Report)’s stock price was down 0.6% during trading on Wednesday . The stock traded as low as C$1.59 and last traded at C$1.60. Approximately 1,323,345 shares traded hands during trading, a decline of 43% from the average daily volume of 2,306,358 shares. The stock had previously closed at C$1.61.
Analysts Set New Price Targets
Several research firms have recently weighed in on WEED. Sanford C. Bernstein reduced their price objective on Canopy Growth from C$5.30 to C$2.50 in a research note on Wednesday, January 14th. Benchmark raised shares of Canopy Growth from a “sell” rating to a “hold” rating in a research report on Monday, November 10th. Finally, ATB Cormark Capital Markets reduced their price target on shares of Canopy Growth from C$1.60 to C$1.40 and set an “underperform” rating on the stock in a research report on Thursday, December 11th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Reduce” and a consensus price target of C$1.95.
View Our Latest Analysis on WEED
Canopy Growth Trading Down 0.6%
Canopy Growth (TSE:WEED – Get Free Report) last released its quarterly earnings results on Friday, February 6th. The company reported C($0.18) EPS for the quarter. Canopy Growth had a negative return on equity of 108.18% and a negative net margin of 201.27%.The company had revenue of C$74.54 million for the quarter. As a group, research analysts expect that Canopy Growth Corp will post -0.69 EPS for the current fiscal year.
Canopy Growth Company Profile
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands.
Featured Stories
- Five stocks we like better than Canopy Growth
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.
